ARS Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 10.86 M | $126.53 M | 0.00% | 10.99% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 8.29 M | $96.56 M | 0.00% | 8.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 7.50 M | $87.42 M | 0.00% | 7.59% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/13/2026 | 6.20 M | $72.23 M | 37.78% | 6.27% |
| BLACKROCK, INC. | 02/12/2026 | 5.09 M | $59.24 M | 5.26% | 5.15% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/12/2026 | 4.01 M | $46.75 M | 0.00% | 4.06% |
| ABRDN PLC | 01/16/2026 | 3.56 M | $41.43 M | 14.82% | 3.60% |
| VANGUARD GROUP INC | 01/29/2026 | 3.51 M | $40.88 M | 0.25% | 3.55% |
| STATE STREET CORP | 02/13/2026 | 3.22 M | $37.55 M | 11.34% | 3.26% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.17 M | $36.91 M | 100.00% | 3.21% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.54 M | $29.63 M | 6.05% | 2.57% |
| UBS GROUP AG | 01/29/2026 | 2.21 M | $25.76 M | 235.04% | 2.24% |
| TYRO CAPITAL MANAGEMENT LLC | 02/13/2026 | 1.99 M | $23.24 M | 100.00% | 2.02% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.95 M | $22.77 M | 23.23% | 1.98% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 1.60 M | $18.64 M | 0.00% | 1.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.55 M | $18.09 M | 3.14% | 1.57% |
| SOUTHPOINT CAPITAL ADVISORS LP | 02/17/2026 | 1.50 M | $17.48 M | 0.00% | 1.52% |
| JANNEY MONTGOMERY SCOTT LLC | 02/11/2026 | 1.29 M | $15.00 M | 6.17% | 1.30% |
| BAMCO INC /NY/ | 02/17/2026 | 1.27 M | $14.78 M | 0.00% | 1.28% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 812.04 K | $9.46 M | -38.75% | 0.82% |
| FIL LTD | 02/17/2026 | 810.07 K | $9.44 M | 100.00% | 0.82% |
| LEVIN CAPITAL STRATEGIES, L.P. | 01/30/2026 | 747.51 K | $8.71 M | -2.20% | 0.76% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 660.70 K | $7.70 M | 0.00% | 0.67% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 643.41 K | $7.50 M | 100.00% | 0.65% |
| CENTERBOOK PARTNERS LP | 02/11/2026 | 568.36 K | $6.62 M | 10.93% | 0.58% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 566.06 K | $6.59 M | -25.16% | 0.57% |
| GENERAL AMERICAN INVESTORS CO INC | 02/13/2026 | 559.96 K | $6.52 M | 100.00% | 0.57% |
| THIRD POINT LLC | 02/17/2026 | 556.24 K | $6.48 M | 100.00% | 0.56% |
| MORGAN STANLEY | 02/13/2026 | 552.36 K | $6.44 M | -21.14% | 0.56% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 550.93 K | $6.42 M | 5.79% | 0.56% |
| NORTHERN TRUST CORP | 02/17/2026 | 521.01 K | $6.07 M | -1.97% | 0.53% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 482.08 K | $5.62 M | 77.22% | 0.49% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 455.77 K | $5.31 M | 100.00% | 0.46% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 418.88 K | $4.88 M | 7.38% | 0.42% |
| JPMORGAN CHASE & CO | 02/11/2026 | 417.09 K | $4.86 M | 1,089.68% | 0.42% |
| FMR LLC | 02/17/2026 | 398.96 K | $4.65 M | -46.27% | 0.40% |
| LISANTI CAPITAL GROWTH, LLC | 02/09/2026 | 396.51 K | $4.62 M | 87.75% | 0.40% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 369.57 K | $4.31 M | 523.96% | 0.37% |
| EMPIRE LIFE INVESTMENTS INC. | 02/04/2026 | 352.60 K | $4.11 M | -0.87% | 0.36% |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 02/03/2026 | 311.50 K | $3.63 M | 100.00% | 0.32% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 304.45 K | $3.55 M | -9.16% | 0.31% |
| 02/18/2026 | 295.86 K | $3.45 M | 100.00% | 0.30% | |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 251.59 K | $2.93 M | -74.24% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 226.80 K | $2.64 M | -12.87% | 0.23% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 216.30 K | $2.52 M | 47.45% | 0.22% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 207.05 K | $2.41 M | 100.00% | 0.21% |
| FAS WEALTH PARTNERS, INC. | 02/18/2026 | 202.41 K | $2.36 M | 0.89% | 0.20% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 201.47 K | $2.35 M | 100.00% | 0.20% |
| BARCLAYS PLC | 02/13/2026 | 196.39 K | $2.29 M | -14.08% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 190.07 K | $2.21 M | 35.28% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 229 institutional investors and hedge funds held shares of ARS Pharmaceuticals Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
ORBIMED ADVISORS LLC: 8.29 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 7.5 M
Rubric Capital Management LP: 6.2 M
BlackRock, Inc.: 5.09 M
SR ONE CAPITAL MANAGEMENT, LP: 4.01 M
90.05% of ARS Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 94.54 M shares in the last 24 months. This purchase volume represents approximately $959.58 M in transactions.